drugset / Trial / NCT00635882
Asthma Study Comparing Anti-Inflammatory Effects of 3 Doses of Mometasone Furoate/Formoterol Fumarate and Medium Dose Mometasone Furoate (Study P05122 AM1)(COMPLETED)
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a 2-week double-blind, placebo-controlled, parallel group study comparing the anti-inflammatory effects of low, medium, and high dose mometasone furoate/formoterol fumarate (MF/F) metered dose inhaler (MDI) formulation and medium dose mometasone furoate (MF) dry powder inhaler (DPI) and MDI formulations in adults and adolescents with persistent allergic asthma.
Timeline
- Start
- 2008-02
- Primary completion
- 2009-06
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Formoterol | Other / unclassified | 10 ug | Inhaled |
| Subject | Mometasone furoate | Other / unclassified | 100 ug | Inhaled |
| Subject | Mometasone furoate | Other / unclassified | 200 ug | Inhaled |
| Subject | Mometasone furoate | Other / unclassified | 400 ug | Inhaled |